Skip to main content

Table 5 Review of etiological characteristics of patient cohorts in previous studies of PHT

From: The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis

Study (year)

Patients

Etiology

  

HBV

HCV

Alcohol

Others*

Nagasue et al. (1999) [36]

63

16 (25.40%)

29 (46.03%)

—

18 (28.57%)

Llovet, J. M. (1999) [3]

164

17 (10.37%)

122 (74.39%)

16 (9.76%)

9 (5.49%)

Ripoll, C. (2005) [37]

393

35(8.9%)

142(36.1%)

172(43.8%)

44 (11.20%)

An M (2006) [6]

142

115 (80.99%)

6 (4.23%)

—

21 (14.79%)

Capussotti, L. (2006) [8]

217

43 (19.82%)

105 (48.39%)

62 (28.57%)

7 (3.23%)

Minagawa, M. (2007) [5]

13566

2682 (19.77%)

9025 (66.53%)

3063 (22.58%)

—

Kawano, Y. (2008) [9]

134

29 (21.64%)

75 (55.97%)

—

30 (22.39%)

Ishizawa T (2008) [10]

386

75 (19.43%)

251 (65.03%)

—

 

Cucchetti, A. (2009) [4]

241

37 (15.35%)

162 (67.22%)

—

42 (17.43%)

Choi, G. H. (2011) [7]

100

77 (77%)

—

—

—

Boleslawski, E. (2012) [25]

40

5 (12.5%)

30 (75%)

5 (12.5%)

 

Santambrogio, R. (2013) [11]

223

38 (17.04%)

135 (60.54%)

—

50 (22.41%)

  1. *Others etiologies include HBV + HCV, hemochromatosis, metabolic, cholestasis and unknown factors.